Lactoferrin as potential supplementary nutraceutical agent in COVID-19 patients: in vitro and in vivo preliminary evidences
E. Campione, C. Lanna, T. Cosio, L. Rosa, M. P. Conte, F. Iacovelli, A. Romeo, M. Falconi, C. Del Vecchio, E. Franchin, M. S. Lia, M. Minieri, C. Chiaramonte, M. Ciotti, M. Nuccetelli, , L. Bianchi
This paper investigates lactoferrin's antiviral activity against SARS-CoV-2 through in vitro and in vivo studies, showing it reduces viral RNA conversion time and inflammation markers in COVID-19 patients.
bioRxiv · Aug 11, 2020 · PreprintMicrobiology